Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic

Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic.

It can be given every 2 weeks in a clinic.

This could help patients who have trouble taking their meds...and possibly decrease the chance of hospitalization for relapse.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote